Mechanism of Action

Sinkcan demonstrates anti-inflammatory properties by reducing levels of IL4, IL5, IL13, Immunoglobin, INOS suppression, and COX2 inhibition. Moreover, it modulates the immune system through GB2 receptor activation and IL4 suppression, while also enhancing IFN gamma cytokine production.

In its approach to combating cancer, Sinkcan employs a dual strategy, aiming to disrupt cancer cell survival and growth while preserving healthy cells. Firstly, it targets glycolysis, a vital metabolic pathway for cancer cells, potentially improving chemotherapy effectiveness by sensitizing cancer cells. This strategy exploits cancer cells' reliance on glycolysis for energy, sparing healthy cells.

Secondly, Sinkcan triggers apoptosis, the self-destruction of cancer cells, and interferes with the cell cycle to hinder unchecked cell division. Additionally, it impedes cancer cell spread and angiogenesis, limiting metastasis. By integrating these mechanisms, Sinkcan offers a comprehensive cancer-fighting approach, addressing both cancer cell energy production and proliferation.

This amalgamation of traditional herbal remedies and modern medicine holds promise in enhancing cancer treatment outcomes while minimizing side effects.